Asset
SGR-1505
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05544019 | phase1 | recruiting | 2023-04-10 | 2027-11-01 | Schrödinger, Inc. | Study of SGR-1505 in Mature B-Cell Neoplasms |
FDA applications (0)
This company has no applications containing this asset.